Rixiong Luo – Trademark Portfolio
Entity Type: 01
Rixiong Luo owns a portfolio of 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as UWEWAY, VZMORE, DR.VIFOO, HONOROSE, and SEEDREAM. Of these, 7 are registered. The portfolio spans 6 Nice Classification classes, led by Class 5 (Pharmaceuticals) and Class 1 (Chemicals). Headquartered in Hunan Province.
Longxipu Town, Wugang City
No.35, Group 12, Luolanqiao Village,
Hunan Province 422400 , CN
Showing of trademarks Trademarks
Trademark Classifications
Rixiong Luo's trademark portfolio spans 6 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Lace and embroidery, ribbons and braid; buttons, hooks and eyes, pins and needles
Frequently Asked Questions
How many trademarks does Rixiong Luo have?
Rixiong Luo has 7 U.S. trademarks filed with the USPTO. Of these, 7 registered.
What trademark classes does Rixiong Luo file in?
Rixiong Luo files trademarks across 6 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals), Class 9 (Computers & Electronics), Class 26 (Fancy Goods), Class 21 (Housewares). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Rixiong Luo's most well-known trademarks?
Rixiong Luo's registered trademark portfolio includes well-known marks such as UWEWAY, VZMORE, DR.VIFOO, HONOROSE, and SEEDREAM. These are among 7 currently registered trademarks in the portfolio.
What is Rixiong Luo's trademark registration success rate?
Rixiong Luo has a 100% trademark registration rate, with 7 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.